CD79A and COVID-19: These studies indicate that individuals with a lack of saliva IgA antibodies, or individuals with negative reactions between saliva IgA antibodies and SARS-CoV-2, have a high risk of virus infection [104], which may also be the reason for the ineffectiveness of severe COVID-19 vaccine [105].